Therapy

"Therapy" References in the ICD-10-CM Index to Diseases and Injuries

References in the ICD-10-CM Index to Diseases and Injuries applicable to the clinical term "therapy"

  • Therapy
    • drug, long-term (current) (prophylactic)
      • agents affecting estrogen receptors and estrogen levels NEC - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • anastrozole (Arimidex) - Z79.811 Long term (current) use of aromatase inhibitors
      • antibiotics - Z79.2 Long term (current) use of antibiotics
        • short-term use - omit code
      • anticoagulants - Z79.01 Long term (current) use of anticoagulants
      • anti-inflammatory - Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
      • antiplatelet - Z79.02 Long term (current) use of antithrombotics/antiplatelets
      • antithrombotics - Z79.02 Long term (current) use of antithrombotics/antiplatelets
      • aromatase inhibitors - Z79.811 Long term (current) use of aromatase inhibitors
      • aspirin - Z79.82 Long term (current) use of aspirin
      • birth control pill or patch - Z79.3 Long term (current) use of hormonal contraceptives
      • bisphosphonates - Z79.83 Long term (current) use of bisphosphonates
      • contraceptive, oral - Z79.3 Long term (current) use of hormonal contraceptives
      • drug, specified NEC - Z79.899 Other long term (current) drug therapy
      • estrogen receptor downregulators - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • Evista - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
      • exemestane (Aromasin) - Z79.811 Long term (current) use of aromatase inhibitors
      • Fareston - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
      • fulvestrant (Faslodex) - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • gonadotropin-releasing hormone (GnRH) agonist - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • goserelin acetate (Zoladex) - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • hormone replacement - Z79.890 Hormone replacement therapy
      • insulin - Z79.4 Long term (current) use of insulin
      • letrozole (Femara) - Z79.811 Long term (current) use of aromatase inhibitors
      • leuprolide acetate (leuprorelin) (Lupron) - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • megestrol acetate (Megace) - Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
      • methadone
        • for pain management - Z79.891 Long term (current) use of opiate analgesic
        • maintenance therapy - F11.20 Opioid dependence, uncomplicated
      • Nolvadex - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
      • opiate analgesic - Z79.891 Long term (current) use of opiate analgesic
      • oral contraceptive - Z79.3 Long term (current) use of hormonal contraceptives
      • raloxifene (Evista) - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
      • selective estrogen receptor modulators (SERMs) - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
      • short term - omit code
      • steroids
        • inhaled - Z79.51 Long term (current) use of inhaled steroids
        • systemic - Z79.52 Long term (current) use of systemic steroids
      • tamoxifen (Nolvadex) - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
      • toremifene (Fareston) - Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)

Applicable Clinical Terms Definitions

Anticoagulants: Agents that prevent BLOOD CLOTTING.

Aromatase Inhibitors: Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)

Insulin: A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).

Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)

Steroids: A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)

Therapeutics: Procedures concerned with the remedial treatment or prevention of diseases.